Treatment Outcomes in Anaplastic Thyroid Cancer

BACKGROUND: Anaplastic thyroid cancer (ATC) is rare, accounting for 1-2% of thyroid malignancies. Median survival is only 3-10 months, and the optimal therapeutic approach has not been established. This study aimed to evaluate outcomes in ATC based on treatment modality. METHODS: Retrospective revie...

Descripción completa

Detalles Bibliográficos
Autores principales: Corrigan, Kelsey L., Williamson, Hannah, Elliott Range, Danielle, Niedzwiecki, Donna, Brizel, David M., Mowery, Yvonne M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556325/
https://www.ncbi.nlm.nih.gov/pubmed/31249658
http://dx.doi.org/10.1155/2019/8218949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556325/
https://www.ncbi.nlm.nih.gov/pubmed/31249658
http://dx.doi.org/10.1155/2019/8218949

Ejemplares similares